High-Dose Vitamin C Therapy Proven Effective

[Guest guest]

FOR IMMEDIATE RELEASE

Orthomolecular Medicine News Service, January 5, 2010

 

 

High-Dose Vitamin C Therapy Proven Effective " My doctor doesn't believe in

vitamins. " Since when is medicine based on belief?

 

 

 

(OMNS, January 5, 2010) The medical literature has virtually ignored 75

years of physician reports and laboratory and clinical studies on successful

high-dose vitamin C therapy.

 

 

 

Effective doses are high doses, often 1,000 times more than the US

Recommended Dietary Allowance (RDA) or Daily Reference Intake (DRI). It is a

cornerstone of medical science that dose affects treatment outcome. This

premise

is accepted with pharmaceutical drug therapy, but not with vitamin

therapy. Most unsuccessful vitamin C research has used inadequate, low doses.

Low

doses do not get clinical results.

 

 

Investigators using vitamin C in high doses have consistently reported

excellent results. High doses were advocated almost immediately after ascorbic

acid was isolated by Albert Szent-Gyorgyi, M.D. (1893-1986). Notable early

medical pioneers of high-dose vitamin C (ascorbate) therapy are Claus

Washington Jungeblut, M.D. (1898-1976); William J. McCormick, M.D. (1880-1968);

and Frederick R. Klenner, M.D. (1907-1984). More recently, important work

has been published by Hugh D. Riordan, M.D. (1932-2005) and Robert F.

Cathcart III, M.D. (1932-2007).

 

 

It Was 75 Years Ago Today

 

 

Dr. Jungeblut, Professor of Bacteriology at Columbia University, first

published on vitamin C as prevention and treatment for polio, in 1935. (1)

Also in 1935, Jungeblut showed that vitamin C inactivated diphtheria toxin.

(2) By 1937, Jungeblut demonstrated that ascorbate inactivated tetanus toxin.

(3) Between 1943 and 1947, Dr. Klenner, a specialist in diseases of the

chest, cured 41 cases of viral pneumonia with vitamin C. By 1946, Dr.

McCormick showed how vitamin C prevents and also cures kidney stones; by 1957,

how

it fights cardiovascular disease. Beginning in the 1960s, Dr. Cathcart used

large doses of vitamin C to treat pneumonia, hepatitis, and eventually

AIDS. For more than three decades, beginning in 1975, Dr. Riordan and his team

have successfully used large doses of intravenous vitamin C against

cancer. The use of doses of tens of thousands of milligrams of vitamin C per

day

may be the most unacknowledged successful research in medicine.

 

 

Heard this one before? " If vitamin C was that good, doctors would tell

their patients to take a lot of it. " It is surprising how many physicians have

done precisely that.

 

 

What's that? Your doctor still doesn't?

 

 

Why? Decades of physicians' reports and controlled studies support the use

of very large doses of vitamin C.

 

 

References:

 

(1) Jungeblut CW. Inactivation of poliomyelitis virus by crystalline

vitamin C (ascorbic acid). J Exper Med 1935. 62:317-321.

 

(2) Jungeblut CW, Zwemer RL. Inactivation of diphtheria toxin in vivo and

in vitro by crystalline vitamin C (ascorbic acid). Proc Soc Exper Biol Med

1935; 32:1229-34.

 

(3) Jungeblut CW. Inactivation of tetanus toxin by crystalline vitamin C

(l-ascorbic acid). J Immunol 1937;33:203-214.

 

 

For More Information About:

 

Dr. CW Jungeblut: Claus Washington Jungeblut, M.D.: Polio pioneer;

ascorbate advocate. J Orthomolecular Med, 2006. Vol 21, No 2, p 102-106.

_http://www.doctoryourself.com/jungeblut.html_

(http://www.doctoryourself.com/jungeblut.html)

 

 

In addition to (1) above, Dr. Jungeblut's other polio papers include:

 

-- Jungeblut CW. Vitamin C therapy and prophylaxis in experimental

poliomyelitis. J Exp Med, 1937. 65: 127-146.

 

-- Jungeblut CW. Further observations on vitamin C therapy in experimental

poliomyelitis. J Exper Med, 1937. 66: 459-477.

 

-- Jungeblut CW, Feiner RR. Vitamin C content of monkey tissues in

experimental poliomyelitis. J Exper Med, 1937. 66: 479-491.

 

-- Jungeblut CW. A further contribution to vitamin C therapy in

experimental poliomyelitis. J Exper Med, 1939. 70:315-332.

 

Jungeblut's research published in the Journal of Experimental Medicine is

available for free access at _http://www.jem.org/contents-by-date.0.shtml_

(http://www.jem.org/contents-by-date.0.shtml)

 

 

Dr. FR Klenner: Hidden in plain sight: the pioneering work of Frederick

Robert Klenner, M.D. J Orthomolecular Med, 2007. Vol 22, No 1, p 31-38.

_http://www.doctoryourself.com/klennerbio.html_

(http://www.doctoryourself.com/klennerbio.html) and

_http://orthomolecular.org/hof/2005/fklenner.html_

(http://orthomolecular.org/hof/2005/fklenner.html)

 

 

Dr. WJ McCormick: The pioneering work of William J. McCormick, M.D. J

Orthomolecular Med, 2003. Vol 18, No 2, p 93-96.

_http://www.doctoryourself.com/mccormick.html_

(http://www.doctoryourself.com/mccormick.html) and

_http://orthomolecular.org/hof/2004/wmccormick.html_

(http://orthomolecular.org/hof/2004/wmccormick.html)

 

 

Dr. RF Cathcart: _http://orthomolecular.org/hof/2008/cathcart.html_

(http://orthomolecular.org/hof/2008/cathcart.html) ;

_http://www.doctoryourself.com/titration.html_

(http://www.doctoryourself.com/titration.html) and

_http://www.doctoryourself.com/biblio_cathcart.html_

(http://www.doctoryourself.com/biblio_cathcart.html)

 

 

Dr. HD Riordan: _http://orthomolecular.org/hof/2005/hriordan.html_

(http://orthomolecular.org/hof/2005/hriordan.html) ;

_http://orthomolecular.org/resources/omns/v01n09.shtml_

(http://orthomolecular.org/resources/omns/v01n09.shtml) ;

_http://www.doctoryourself.com/riordan1.html_

(http://www.doctoryourself.com/riordan1.html) and

_http://www.doctoryourself.com/biblio_riordan.html_

(http://www.doctoryourself.com/biblio_riordan.html)

 

 

Nutritional Medicine is Orthomolecular Medicine

 

Orthomolecular medicine uses safe, effective nutritional therapy to fight

illness. For more information: _http://www.orthomolecular.org_

(http://www.orthomolecular.org/)

 

 

The peer-reviewed Orthomolecular Medicine News Service is a non-profit and

non-commercial informational resource.

 

 

 

Editorial Review Board:

 

Carolyn Dean, M.D., N.D.

Damien Downing, M.D.

Michael Gonzalez, D.Sc., Ph.D.

Steve Hickey, Ph.D.

James A. Jackson, PhD

Bo H. Jonsson, MD, Ph.D

Thomas Levy, M.D., J.D.

Jorge R. Miranda-Massari, Pharm.D.

Erik Paterson, M.D.

Gert E. Shuitemaker, Ph.D.

 

 

Andrew W. Saul, Ph.D., Editor and contact person.

Email: _omns_ (omns)

 

 

To Subscribe at no charge: _http://www.orthomolecular.org/.html_

(http://www.orthomolecular.org/.html)

 

 

 

__

This article may be reprinted free of charge provided 1) that there is

clear attribution to the Orthomolecular Medicine News Service, and 2) that

both the OMNS free subscription link

_http://orthomolecular.org/.html_

(http://www.cihfimediaservices.org/12all/lt/t_go.php?i=42 & e=MTM0MTk= & l=-http--or\

thomolecular.org/.html) and also the OMNS archive link

_http://orthomolecular.org/resources/omns/index.shtml_

(http://www.cihfimediaservices.org/12all/lt/t_go.php?i=42 & e=MTM0MTk= & l=-http--or\

thomolecular.org/resou

rces/omns/index.shtml) are included.